Cannabidiol is associated with 49.9% seizure reduction in patients with Developmental and Epileptic Encephalopathies
Cannabidiol shows significant seizure reduction in some DEE patients
This meta-analysis of 2592 individuals with Developmental and Epileptic Encephalopathies (DEEs) found that pharmaceutical-grade cannabidiol …
Pharmaceutical-grade cannabidiol may help nearly half of people with certain severe epilepsy syndromes reduce their seizures by at least 50 …
Review synthesizes IQSEC2 variant features in developmental encephalopathy and Rett-like syndrome cases
New Clue Solves Mystery Behind Boys With Rett-Like Symptoms
This case report and literature review synthesizes data from two brothers, their mother, and 38 published cases of IQSEC2-related conditions…
• IQSEC2 gene mutations explain Rett-like symptoms in boys • Helps families with undiagnosed developmental delays and seizures • Genetic tes…
Genome sequencing identified diagnoses in 15% of individuals with unsolved developmental and epileptic encephalopathies
Genome sequencing finds diagnoses in 15% of unsolved epilepsy cases
This cohort study included 242 individuals with unsolved developmental and epileptic encephalopathies who were negative on prior genetic tes…
Genome sequencing identified a molecular diagnosis in 15% of people with unsolved epilepsy who had negative prior genetic testing results.
Atypical absences linked to higher autistic behavior scores in SYNGAP1-DEE patients
Seizure Type Predicts Autism Severity Better Than Frequency Does
This observational cohort study of 337 patients with SYNGAP1-related developmental and epileptic encephalopathy found that atypical absences…
For children with this rare condition, the kind of seizure matters more for autism symptoms than how often they occur.
Case series and literature review expands phenotypic spectrum of germline PIGA variants
Do fever spikes make seizures worse in children with specific genetic epilepsy?
This case series and literature review describes five germline PIGA missense pathogenic/likely pathogenic variants across six unrelated fami…
Every child with this rare epilepsy gene change reacts to fever, while specific genetic spots determine if symptoms are severe or mild.
Case report describes complex FBRSL1 variant in infant with developmental and epileptic encephalopathy
Doctors describe a new genetic finding in an infant with severe developmental disorder
A case report describes an infant girl with profound developmental and epileptic encephalopathy (DEE) and multiple congenital abnormalities.
A new genetic change in the FBRSL1 gene causes severe seizures and developmental delays in an infant, expanding what doctors know about this…
Research across Epilepsy
Related studies from across the Epilepsy family.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.
Modified prednisone regimen shows short-term ineffectiveness in infantile epileptic spasms syndrome based on retrospective cohort data
Blood marker may predict prednisone response in infantile spasms
This retrospective cohort study evaluated 66 IESS patients and 53 age-matched healthy controls.
A blood protein called HMGB1 may help doctors quickly tell if prednisone will work for infantile spasms.
Machine learning model predicts seizure outcomes in pediatric infantile epileptic spasms syndrome
New AI Tool Predicts Seizure Risks in Babies
This retrospective cohort study evaluated a machine learning model in pediatric patients with infantile epileptic spasms syndrome at Wuhan C…
A new computer tool predicts seizure risks in babies with infantile epileptic spasms syndrome, helping doctors plan faster care.
Questions about Developmental and Epileptic Encephalopathies
Does cannabidiol help reduce seizures in patients with Developmental and Epileptic Encephalopathies?
Yes, cannabidiol (CBD) helps reduce seizures in patients with Developmental and Epileptic Encephalopathies, with about 49.9% seizure reduction in meta-analyses and 69% of patients achieving ≥50% reduction in real-world studies.
Full answer →